These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24037995)

  • 1. Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions.
    Gahr M; Freudenmann RW; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2013 Dec; 53(12):1328-33. PubMed ID: 24037995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin abuse and dependence in Germany: results from a database query.
    Gahr M; Freudenmann RW; Hiemke C; Kölle MA; Schönfeldt-Lecuona C
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1335-42. PubMed ID: 23292158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse liability of centrally acting non-opioid analgesics and muscle relaxants--a brief update based on a comparison of pharmacovigilance data and evidence from the literature.
    Gahr M; Freudenmann RW; Eller J; Schönfeldt-Lecuona C
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):957-9. PubMed ID: 24552880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
    Herrmann WM; Kern U; Aigner M
    Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals.
    Sofia RD; Diamantis W; Gordon R
    Postgrad Med J; 1987; 63 Suppl 3():35-40. PubMed ID: 3447127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting.
    Anderson N; Borlak J
    PLoS One; 2011; 6(10):e25221. PubMed ID: 22022383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
    Nickel B; Borbe HO; Szelenyi I
    Arzneimittelforschung; 1990 Aug; 40(8):905-8. PubMed ID: 1978681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Orzechowski HD; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2014 Apr; 70(4):453-9. PubMed ID: 24366502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tramadol dependence: a survey of spontaneously reported cases in Sweden.
    Tjäderborn M; Jönsson AK; Ahlner J; Hägg S
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1192-8. PubMed ID: 19827010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flupirtine in patients with cancer pain].
    Scheef W; Wolf-Gruber D
    Arzneimittelforschung; 1985; 35(1):75-7. PubMed ID: 3885963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of flupirtine leads to withdrawal symptoms and is associated with dependency.
    Wielopolski J; Reich K; Clepce M; Kornhuber J; Thuerauf N
    Pharmacopsychiatry; 2013 Nov; 46(7):292-3. PubMed ID: 24065566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term tolerance of flupirtine. Open multicenter study over one year].
    Herrmann WM; Hiersemenzel R; Aigner M; Lobisch M; Riethmüller-Winzen H; Michel I
    Fortschr Med; 1993 May; 111(15):266-70. PubMed ID: 8330823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple drug dependence].
    Beisel J; Müller O; Wegener B
    Gesundheitswesen; 1993 Apr; 55(4):185-9. PubMed ID: 8507995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid use by patients in an orthopedics spine clinic.
    Mahowald ML; Singh JA; Majeski P
    Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use and substance use disorders in a community sample of adolescents and young adults: incidence, age effects and patterns of use.
    Perkonigg A; Pfister H; Hofler M; Frohlich C; Zimmermann P; Lieb R; Wittchen HU
    Eur Addict Res; 2006; 12(4):187-96. PubMed ID: 16968994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term prognosis of analgesics abuse headache].
    Takase Y; Kishigami H; Nakano M; Tatsumi C
    Rinsho Shinkeigaku; 2005 Sep; 45(9):629-33. PubMed ID: 16248393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.